Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Health Group's earnings per share without non-recurring items for the
six
months ended in Mar. 2026 was HK$-0.02.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was HK$-0.04.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 6.70% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -19.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for China Health Group's EPS without NRI or its related term are showing as below:
HKSE:00673'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -71.2 Med: 15.7 Max: 60.2
Current: 6.7
During the past 13 years, China Health Group's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 60.20% per year. The lowest was -71.20% per year. And the median was 15.70% per year.
HKSE:00673's 3-Year EPS without NRI Growth Rate is ranked better than 53% of 100
companies
in the Medical Distribution industry
Industry Median: 4.15
vs HKSE:00673: 6.70
China Health Group's EPS (Basic) for the
six
months ended in Mar. 2026 was HK$-0.03.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was HK$-0.05.
China Health Group (HKSE:00673) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
China Health Group EPS without NRI Related Terms
China Health Group EPS without NRI Historical Data
* Premium members only.
The historical data trend for China Health Group's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00673 vs MCK, COR, CAH: EPS without NRI Comparison
For the Medical Distribution subindustry, China Health Group's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Group PE Ratio without NRI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China Health Group's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where China Health Group's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Group (HKSE:00673) has a EPS without NRI of HK$-0.04 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on China Health Group and its competitors. According to the industry distribution chart, China Health Group ranks #47 out of 100 companies in the Medical Distribution industry, placing it in the top 47%.
Is China Health Group's EPS without NRI too high?
China Health Group's current EPS without NRI is HK$-0.04. Based on the distribution chart, China Health Group ranks #47 out of 100 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, China Health Group has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Health Group's EPS without NRI compare to MCK and COR?
According to the Medical Distribution industry distribution chart, China Health Group ranks #47 out of 100 companies for EPS without NRI. This puts China Health Group in the upper half of its industry. The industry median EPS without NRI is 4.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Distribution company?
The median EPS without NRI among Medical Distribution companies is 4.15, based on 100 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on China Health Group and its competitors. For the Medical Distribution industry, the median EPS without NRI is 4.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Group's current EPS without NRI is HK$-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Group stock overvalued right now?
Based on GuruFocus' analysis, China Health Group (HKSE:00673) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.24, compared to a current price of HK$0.32 — trading 33.3% above its estimated fair value. The current EPS without NRI is HK$-0.04. China Health Group's overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For China Health Group (HKSE:00673), the current EPS without NRI is HK$-0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Health Group (HKSE:00673) Overvalued in 2026?
Based on GuruFocus' analysis, China Health Group stock appears to be overvalued.
The current stock price of HK$0.32 is trading 33.3% above its estimated GF Value™ of HK$0.24.
GuruFocus considers China Health Group to be Significantly Overvalued.
Key valuation signals for HKSE:00673:
EPS without NRI: HK$-0.04
GF Value™: HK$0.24 vs. price of HK$0.32 (33.3% above fair value)
No single metric tells the full story. See the HKSE:00673 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Health Group Ltd is an investment holding company. It is principally engaged in the distribution and service of medical equipment and consumables, provision of hospital operation and management services, and business factoring. It operates in the business in four segments: medical equipment and consumables distribution and service business; hospital operation and management services business; business service; and research and development and sale of functional food. It derives a majority of revenue from the Distribution and service in the medical equipment and consumables segment. Geographically, the group derives its revenue from the PRC.
24GF Score
Get the complete analysis for HKSE:00673
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00673 has been successfully added to your 
